# Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer

> **NCT06086574** · — · UNKNOWN · sponsor: **University of Manchester** · enrollment: 80 (estimated)

## Conditions studied

- Lung Cancer Stage III

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06086574
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-24
- **Primary completion:** 2024-09-24
- **Final completion:** 2025-09-24
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06086574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06086574, "Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06086574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*